Publications found:
73,128
Sort by:
Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO-IL-11)
US$ 259.00
The Competitive Intelligence Report Thrombopoiesis Stimulating Agents (TPO; IL-11) as of January 2011 provides information on thrombopoiesis stimulating agents targeting the thrombopoietin, interleukin-11 or other receptors on the market and in development. In addition, the report lists company-specific R&D ...
January 2011
21 pages
Competitor Analysis: G-CSF & GM-CSF
US$ 454.00
... report includes a compilation of currently marketed branded and non-branded G-CSF and GM-CSF products in regulated and non-regulated markets for treatment ... products in regulated markets 1st and next generation GM-CSF products in non-regulated markets About La Merie About Competitor Analysis Series: The ...
January 2011
40 pages
Competitor Analysis: Erythropoietin (EPO)
US$ 684.00
Product description The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second generation epoetin products in regulated markets, an overview on biosimilar versions of EPO in ...
January 2011
76 pages
Digital Health Quarterly 1Q 2011 2Q 2011
US$ 1,500.00
The Market Tracker: Digital Health Quarterly offers in-depth analysis of the latest corporate news, industry events, passed and pending legislation, and government directives related to the digital health industry.
January 2011
20 pages
Digital Health Quarterly 2Q 2011 3Q 2011
US$ 1,500.00
The Market Tracker: Digital Health Quarterly offers in-depth analysis of the latest corporate news, industry events, passed and pending legislation, and government directives related to the digital health industry.
January 2011
18 pages
Digital Health Quarterly 3Q 2011 4Q 2011
US$ 1,500.00
The Market Tracker: Digital Health Quarterly offers in-depth analysis of the latest corporate news, industry events, passed and pending legislation, and government directives related to the digital health industry.
January 2011
16 pages
Digital Health Quarterly 4Q 2010 1Q 2011
US$ 1,500.00
The Market Tracker: Digital Health Quarterly offers in-depth analysis of the latest corporate news, industry events, passed and pending legislation, and government directives related to the digital health industry.
January 2011
20 pages
IP-based Health Solutions: Home Care and Beyond 4Q 2011
US$ 3,500.00
... report examines the market for IP-based monitoring solutions that help consumers live safer and healthier at home. It looks into broadband service ... Broadband in the home and wireless broadband connectivity have made it easier to remotely monitor consumers for safety and health concerns. IP-based sensor ...
January 2011
50 pages
Wireless Healthcare (Second Edition) 3Q 2011
US$ 3,500.00
... This report updates the inaugural wireless health report from Parks Associates. It continues to profile innovations in both wireless technology-supported personal health ... growth potentials. “Parks Associates believes that mobile technology and wireless connectivity will greatly enhance the appeal of personal health applications ...
January 2011
54 pages
Closing the Loop: Beyond Digital Detailing
US$ 395.00
Imagine this: Nearly all the puzzle pieces are in place. The picture is clear, but not yet finished. One part remains. But no matter how you try, something stops it from fitting it in place. For the p...
November 2010
48 pages
Competitor Analysis: Sphingosine-1-Phosphate (S1P)
US$ 277.00
Product description The present Competitive Intelligence Report about Sphingosine-1-Phosphate (S1P) provides a competitor evaluation in the field of molecules interacting with the sphingosine-1-phosphate pathway as of November 2010. Among these molecules are S1P and selective S1P1 receptor agonists or S1P ...
November 2010
26 pages
Competitor Analysis p38 MAPK Inhibitors
US$ 273.00
... would be expected to decrease the production of these cytokines. About ten p38 MAPK inhibitors are in clinical phase I and II studies, with the first ... leading to the source of information. Index p38 MAPK Inhibitors p38 alpha MAPK Inhibitors About La Merie About Competitor Analysis Series: The ...
November 2010
21 pages
Competitor Analysis Interleukin-6 (IL-6) and Receptor (IL-6R) Antagonists
US$ 205.00
... IL-6R Antagonists in Inflammation IL-6 and IL-6R Antagonists in Oncology Small Molecule Approaches of IL-6 and IL-6R Antagonists About La Merie About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, ...
November 2010
20 pages
Romania Dental Market Analysis
US$ 400.00
Single User PDF Format: US$ 400.00 Multi-User License: US$ 800.00 Hard Copy: US$ 500.00 CD-ROM: US$ 500.00 Romania has emerged as one of the most popular destinations in Europe for dental treatments...
October 2010
30 pages
Competitor Analysis Toll-Like Receptor (TLR) Agonists & Antagonists
US$ 800.00
... description The Competitive Intelligence Report Toll-Like Receptor (TLR) Agonists & Antagonists provides a competitor analysis in the development pipeline of novel small ... with the project data to print or export an individual report. Toll-like receptors (TLRs) are a class of proteins that play a key role ...
October 2010
144 pages
Global Minimally Invasive Surgery Market (2010 - 2015)
US$ 3,390.00
The technology shift from invasive to minimally invasive surgery (MIS) has brought about significant changes in the field of medicine. ... of critical micro-markets, which have so far remained unexplored. Scope of the report This research report categorizes the global market for minimally invasive surgery devices on the ...
October 2010
251 pages
Competitor Analysis: C5a-R Antagonists
US$ 173.00
... , Target / Mechanism of Action, Class of Compound, Company, Product Category, Indication, R&D Stage and additional comments with a hyperlink leading to the source of information. Index C5 Antagonists C5a Antagonists C5aR Antagonists Corporate C5a & C5aR Antagonist R&D Pipelines About La Merie
October 2010
14 pages
Tomorrow’s KOLs: the Changing Face of Influence
US$ 395.00
In Europe, the US and other key markets, the story is the same: regulatory change, public opinion and cost containment are all changing the face of stakeholders. Where physicians once spoke with the s...
September 2010
49 pages
REMS: A Standardized Approach to Risk Management
US$ 395.00
Risk Evaluation and Mitigation Strategies. Until recently, the Federal Drug Administration’s REMS program impacted drugs that would not have been otherwise approved due to their risks. The hurdles, co...
September 2010
42 pages
Global Radiation Therapy Market: 2010 Edition
US$ 800.00
The global radiation therapy market has witnessed a double digit growth rate during the last ... from developing nations. The report provides an in-depth analysis of the global radiation therapy market. The various drivers, opportunities and the challenges faced by the ...
August 2010
43 pages
Global Coronary Stent Market Report: 2010 Edition
US$ 800.00
... global coronary stents market declined thereafter. Due to the appeal for less invasive percutaneous coronary intervention procedures and advances in technology, the global coronary stents market is forecasted to grow at a CAGR of 3.7%. Coronary ...
August 2010
36 pages
Competitor Analysis: PPAR Agonists
US$ 460.00
... to print or export an individual report. Despite the tremendous attrition rate of PPAR agonist R&D over the last 20 years, the ones in the market ... delta) Corporate PPAR Agonist Product Portfolios and R&D Pipelines About La Merie About Competitor Analysis Series: The Competitor Analysis Series delivers ...
August 2010
45 pages
Atrial Fibrillation: Market Research Report
US$ 3,950.00
... for the period 2006 through 2015. Also, the report provides market revenues for Atrial Fibrillation therapies for the years 2006 through 2015. The ... , Sorin SpA, Spectrasonics, Inc., St. Jude Medical, Inc., and Zimmer Holdings, Inc. Market data and analytics are derived from primary and secondary research. ...
August 2010
301 pages
Tinea Pedis (Athlete's Foot): Market Research Report
US$ 3,450.00
This report analyzes the US market for Tinea Pedis (Athlete's Foot) in US$ Million. Annual estimates and forecasts are provided for the period ... Novartis AG, Sanofi-Aventis, Stiefel Laboratories, Inc., and Topica Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. ...
August 2010
269 pages
Pay-for-Delay: An Unsettled Future Lies Ahead
US$ 395.00
Anti-competitive or just good business?That’s the question facing the pharmaceutical industry and regulators alike, as companies dealing with drugs going off-patent increasingly rely on pay-for-delay...
July 2010
36 pages
Chiropractic Care: Market Research Report
US$ 3,950.00
This report analyzes the US market for Chiropractic Care in US$ Billion. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a six-year historic analysis is provided for this market. The report profiles 112 companies including many key and niche players such ...
July 2010
100 pages
Narcolepsy Therapeutics: Market Research Report
US$ 3,450.00
This report analyzes the Global market for Narcolepsy Therapeutics in US$ Million. Annual estimates and forecasts are provided for the period 2006 ... , Inc., Cephalon, Inc., Evotec AG, Hypnion, Inc., and Jazz Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. ...
July 2010
160 pages
Flat-Rate Subscription to La Merie Reports with 24/7 Online Access
US$ 4,600.00
... Merie and available in the online store during the subscription. Among La Merie reports are more than 100 Competitor Analysis reports as well ... sent to ensure customer support. Features of the Flat-Rate Online Access to La Merie Reports: 24/7 access to all La Merie reports Instant online download of report ...
June 2010
-
ADHD Therapeutics: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for ADHD Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US and ... , Novartis AG, Shire Plc, UCB S.A., Companies with Drugs in Pipeline for ADHD: Abbott Laboratories, Inc., Cortex Pharmaceuticals, Inc., KemPharm, Inc., and ...
June 2010
321 pages
Diabetic Retinopathy: Market Research Report
US$ 3,950.00
This report analyzes the US Market for Diabetic Retinopathy in US$ Million. Annual estimates and forecasts are provided for the period 2011 ... Kenkyusho Co., Ltd., Sirnaomics, Inc., Suzuken Co., Ltd., and Vitreoretinal Technologies, Inc. Market data and analytics are derived from primary and secondary ...
June 2010
325 pages
Kidney Dialysis Centers: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Kidney Dialysis Centers in US$ Million. The report provides separate comprehensive analytics for the ... Euromedic International BV, Fresenius Medical Care AG & Co. KGaA, and Renal Advantage, Inc. Market data and analytics are derived from primary and secondary ...
June 2010
216 pages
Whey Proteins: Market Research Report
US$ 4,500.00
This report analyzes the US and European Markets for Whey Proteins in US$ Million. The US market is also analyzed by volume (Million Pounds (lbs)). The ... 2007 through 2015. Also, a six-year historic analysis is provided for the US market. The report profiles 43 companies including many key and niche players ...
June 2010
177 pages
Australian Healthcare IT Market Analysis
US$ 900.00
Single User PDF Format: US$ 900.00
Multi-User License: US$ 1400.00
Hard Copy: US$ 1000.00
CD-ROM: US$ 1000.00 The current healthcare reform in Australia has induced the rapid transitio...
May 2010
35 pages
Trends in Mobile Medicine: Smartphone Apps for Physicians
US$ 395.00
“Healing is a matter of time,” Hippocrates once said, “but it is sometimes also a matter of opportunity.”As smartphone technology rapidly evolves and puts knowledge literally into the hands of physici...
May 2010
66 pages
2010 U.S. Offices of Podiatrists Industry Report
US$ 149.00
The U.S. Offices of Podiatrists Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2010 current an...
May 2010
240 pages
Oncology Pipeline Database: 1-Year Subscription
US$ 2,070.00
Product description Subscription to La Merie's proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action, Product Category and R&D Phase. Use of the R&D database of cancer drugs is intuitive ...
May 2010
-
The State of Merck & Co
US$ 295.00
New directions. New faces. Major new facilities. As 2009 ended and the curtain lifted on 2010, Merck & Co emerged from its $41.1 billion union with Schering-Plough with a whole new outlook. Starti...
April 2010
38 pages
The State of Roche
US$ 295.00
Expect the unexpected. For pharma giant Roche, those were words to live by as 2009 came to a close. Despite a strong showing in news analysis — of 179 articles published internationally on the compan...
April 2010
39 pages
US Neonatal (Preterm) Infant Care Market (2010-2015)
US$ 3,390.00
... 35 market players. The report categorizes the U.S. Neonatal (Preterm) Infant Care market as follows: Neonatal (Preterm) Infant Care Equipment (Diagnosis, therapy, and monitoring) Neonatal (Preterm) Infant Formula (For use in hospitals, after ... hydrolysate formulas, amino acid formulas) Neonatal (Preterm) Infant Care Drugs (Antibiotics, bronchodilators, analgesics, diuretics, vassopressors, hematologic agents) Neonatal (Preterm) Infant Care Services Market (Diagnosis, therapy, and ...
April 2010
165 pages
IVD Market in BRIC Countries
US$ 3,390.00
Report Description The IVD markets of BRIC economies offer immense growth opportunities due to the increasing healthcare ... is expected to command the largest IVD market among all BRIC economies. Scope of the Report This report categorizes the BRIC IVD market on the basis of: Geography: Brazil ...
April 2010
155 pages
Inflammatory Bowel Disease Therapeutics: Market Research Report
US$ 3,950.00
This report analyzes the Global market for Inflammatory Bowel Disease Therapeutics in US$ Million. Annual estimates and forecasts are provided for the ... Pharmaceutical Co.Ltd., Prometheus Laboratories, Inc., Shire plc, UCB SA, and Wyeth. Market data and analytics are derived from primary and secondary ...
April 2010
611 pages
Acute Coronary Syndrome: Market Research Report
US$ 3,450.00
This report analyzes the global market for Acute Coronary Syndrome Therapeutics in US$ Million. Annual estimates and forecasts are provided for the ... Diagnostics, Inc., Takeda Pharmaceutical Company Limited, and The Medicines Company. Market data and analytics are derived from primary and secondary research. ...
April 2010
752 pages
